Techno Trends
Omega-3 Fatty Acids Help Heart Patients With Stents
Combining omega-3 fatty acids with blood-thinning drugs may reduce the risk of heart attacks in patients who've had stents placed in their coronary arteries, a new European study suggests. While other research suggests that foods rich...
Techno Trends
Novozymes Biopharma collaborates with the University of Oslo to develop enhanced albumin fusion technology
Novozymes Biopharma, part of Novozymes A/S, the world leader in bioinnovation, today unveiled its enhanced next-generation albumin technology, which was developed in collaboration with the University of Oslo, Norway, one of the world’s leading institutions in the research of...
Techno Trends
Topman Announces Exclusive Sunglasses for Rock You Shades Day
Topman is proud to announce it is producing four exclusive designs of sunglasses to help raise much needed funds and increase awareness for the Teenage Cancer Trust and the charity's Rock Your Shades day on Friday 6th May. ...
Techno Trends
Veeva Launches First iPad CRM/CLM Cloud Application
Veeva Systems, the leader in cloud-based business solutions for the global life sciences industry, recently launched iRep, the industry’s first iPad CRM/CLM cloud application for life sciences sales representatives. Veeva’s iRep has made life easier for life sciences sales...
Techno Trends
Cipla introduces new pain free screening technology for early detection of breast cancer in India
Cipla, one of the leading pharmaceutical companies from India, announces the launch of a breakthrough screening technology in India today called the ‘No Touch Breast Scan (NTBS); ' the first-ever painless, non-invasive and radiation-free breast scanning technique for detecting...
Techno Trends
New Technology Platform For Testing Drugs
Birkbeck and Southampton researchers pioneer new technology for pharmaceutical drug developmen for testing drugs will simplify the process and drive new research for the treatment of diseases such as chronic pain, epilepsy, and certain types of heart disease. ...
Techno Trends
Merck KGaA to Introduce RebiDose, the Rebif Single Use Pre-filled Pen for Treatment of Multiple Sclerosis
Merck KGaA announced the upcoming introduction of the new device RebiDose, the Rebif single use pre-filled pen, for the self-administration of Rebif (interferon beta-1a), a disease-modifying drug used to treat relapsing forms of multiple sclerosis (MS). ...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read